Hims & Hers: Eucalyptus Deal Unlocks New Markets (NYSE:HIMS)
· seekingalpha.com
Hims & Hers Health, Inc. is rated a Hold as current market prices exceed my implied fair value of $22 per share. Read more on HIMS stock here.
Since my last article about Hims & Hers Health, Inc. ( HIMS ), the stock has been rising 22%. My initial thesis was that future growth comes from product expans...